On the public citation graph
A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults
0 signed · 35 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/j.antiviral.2018.11.004openalex-extracted
Vaccinating against monkeypox in the Democratic Republic of the Congo
inferredcites →https://doi.org/10.1016/j.biologicals.2014.05.007openalex-extracted
Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
inferredcites →https://doi.org/10.1016/j.ijid.2018.11.008openalex-extracted
Monkeypox — Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era
inferredcites →https://doi.org/10.1016/j.jacc.2003.11.053openalex-extracted
Smallpox vaccination and myopericarditis: a clinical review
inferredcites →https://doi.org/10.1016/j.jacc.2004.05.004openalex-extracted
Incidence and follow-up of inflammatory cardiac complications after smallpox vaccination11The views expressed in this study are those of the authors and do not reflect the official policy or position of the U.S. government.
inferredcites →https://doi.org/10.1016/j.vaccine.2005.11.022openalex-extracted
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2009.05.095openalex-extracted
Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
inferredcites →https://doi.org/10.1016/j.vaccine.2009.11.030openalex-extracted
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
inferredcites →https://doi.org/10.1016/j.vaccine.2014.02.043openalex-extracted
Phase II randomized, double-blinded comparison of a single high dose (5×108 TCID50) of modified vaccinia Ankara compared to a standard dose (1×108 TCID50) in healthy vaccinia-naïve individuals
inferredcites →https://doi.org/10.1016/j.vaccine.2014.08.022openalex-extracted
Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis
inferredcites →https://doi.org/10.1016/j.vaccine.2015.06.075openalex-extracted
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
inferredcites →https://doi.org/10.1016/j.vaccine.2015.08.085openalex-extracted
Freeze-drying of live virus vaccines: A review
inferredcites →https://doi.org/10.1016/j.vaccine.2016.11.097openalex-extracted
The origins of the vaccine cold chain and a glimpse of the future
inferredcites →https://doi.org/10.1016/j.vaccine.2020.01.058openalex-extracted
A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS
inferredcites →https://doi.org/10.1016/j.vaccine.2020.08.050openalex-extracted
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform
inferredcites →https://doi.org/10.1016/j.vaccine.2020.12.046openalex-extracted
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018
inferredcites →https://doi.org/10.1016/s0147-9571(03)00025-0openalex-extracted
Smallpox vaccination and bioterrorism with pox viruses
inferredcites →https://doi.org/10.1056/nejm198011273032204openalex-extracted
The Confirmation and Maintenance of Smallpox Eradication
inferredcites →https://doi.org/10.1056/nejmoa032299openalex-extracted
The Detection of Monkeypox in Humans in the Western Hemisphere
inferredcites →https://doi.org/10.1093/infdis/jis753openalex-extracted
Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects
inferredcites →https://doi.org/10.1093/ofid/ofv040openalex-extracted
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
inferredcites →https://doi.org/10.1371/journal.pntd.0010141openalex-extracted
The changing epidemiology of human monkeypox—A potential threat? A systematic review
inferredcites →https://doi.org/10.1371/journal.pone.0118283openalex-extracted
A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination
inferredcites →https://doi.org/10.1371/journal.pone.0138348openalex-extracted
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis
inferredcites →https://doi.org/10.15585/mmwr.mm6510a2openalex-extracted
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses — Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
inferredcites →https://doi.org/10.15585/mmwr.mm6710a5openalex-extracted
Emergence of Monkeypox — West and Central Africa, 1970–2017
inferredcites →https://doi.org/10.1586/14760584.7.8.1225openalex-extracted
Smallpox vaccines for biodefense: need and feasibility
inferredcites →https://doi.org/10.2807/1560-7917.es.2018.23.38.1800509openalex-extracted
Two cases of monkeypox imported to the United Kingdom, September 2018
inferredcites →https://doi.org/10.3201/eid2505.190076openalex-extracted
Diagnosis of Imported Monkeypox, Israel, 2018
inferredcites →https://doi.org/10.4161/hv.24319openalex-extracted
Unintentional transfer of vaccinia virus associated with smallpox vaccines
inferredcites →https://doi.org/10.7205/milmed-d-12-00226openalex-extracted
Myopericarditis and Pericarditis in the Deployed Military Member: A Retrospective Series
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1080/21645515.2024.2384189openalex-snapshot
Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.